FLUZONE HIGH DOSE NORTHERN HEMISPHERE (INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (A/MISSOURI/11/2025 PDM09-LIKE) by Sanofi Vaccines US Inc.: new vaccine listing
FLUZONE HIGH DOSE NORTHERN HEMISPHERE: new vaccine listing. Dated 126 days ago, it serves as a historical benchmark. Score 80/100. As of 2026-11-04, from U.S. FDA National Drug Code (NDC) Directory via openFDA.
Data as of · Compiled by Zalwin from U.S. FDA National Drug Code (NDC) Directory via openFDA
Free preview: all 12 published fields of this record are shown below. Locked: 17 related FdaNdcDirectoryPulse records and the 5-column CSV export.
| Field | Value |
|---|---|
| Product | FLUZONE HIGH DOSE NORTHERN HEMISPHERE |
| Generic name | INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (A/MISSOURI/11/2025 PDM09-LIKE VIRUS) (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED) |
| NDC | 49281-126 |
| Labeler | Sanofi Vaccines US Inc. |
| Product type | VACCINE |
| Approval pathway | BLA |
| Application number | BLA103914 |
| Dosage form | INJECTION, SUSPENSION |
| Route | INTRAMUSCULAR |
| Active ingredients | INFLUENZA A VIRUS A/SWITZERLAND/6849/2025 IVR-278 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED) 60 ug/.5mL; INFLUENZA A VIRUS A/MICHIGAN/105/2025 SAN-049A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED) 60 ug/.5mL; INFLUENZA B VIRUS B/TOKYO/EIS13-175/2025 ANTIGEN (FORMALDEHYDE INACTIVATED) 60 ug/.5mL |
| Marketing start | 2026-07-02 |
| Package configurations | 1 |
| Peer records CSV (18 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch FLUZONE HIGH DOSE NORTHERN HEMISPHERE
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock FLUZONE HIGH DOSE NORTHERN HEMISPHERE + all 18 records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Product · Labeler · Pathway · Form · Listed · official source URL
- Source agency: U.S. FDA National Drug Code (NDC) Directory via openFDA
- Record date: 2026-07-02
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top FdaNdcDirectoryPulse records (VACCINE first): Cyclophosphamide by Amneal Pharmaceuticals LLC · Cyclophosphamide by Amneal Pharmaceuticals LLC · YESAFILI (aflibercept-jbvf) by Biocon Biologics Inc. · CIPROFLOXACIN OTIC (ciprofloxacin) by Alembic Pharmaceutical · WELTRUZA (olanzapine) by Teva Pharmaceuticals USA, Inc. · Browse all by state and category →
LIVE PUBLIC DATA Source: U.S. FDA National Drug Code (NDC) Directory via openFDA · Last refreshed: Wed, 04 Nov 2026 18:12:05 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: FLUZONE HIGH DOSE NORTHERN HEMISPHERE and 18 VACCINE peers
- VACCINE FdaNdcDirectoryPulse records like this one: 18
- Timing: Low: older than 30 days
- Estimated pipeline if you contact every VACCINE peer: $3,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
80 / 100 Launch Signal Score
- Prescription or biologic product.
- Brand or biologic launch.
- Injectable: hospital and 503B relevance.
What is the FdaNdcDirectoryPulse record for FLUZONE HIGH DOSE NORTHERN HEMISPHERE?
FLUZONE HIGH DOSE NORTHERN HEMISPHERE by Sanofi Vaccines US Inc.: new vaccine listing (BLA) starting 2026-07-02.
How does FLUZONE HIGH DOSE NORTHERN HEMISPHERE compare to other FdaNdcDirectoryPulse records?
It is 126 days old; check the official source for later updates before acting. Its Launch Signal Score of 80/100 puts it among the stronger signals in this feed.
FLUZONE HIGH DOSE NORTHERN HEMISPHERE vs. top 3 peers
| Organization | Location | Record date |
|---|---|---|
| FLUZONE HIGH DOSE NORTHERN HEMISPHERE | VACCINE | 2026-07-02 |
| Comirnaty | VACCINE | 2026-08-27 |
| NUVAXOVID 2026-27 | VACCINE | 2026-08-27 |
| Comirnaty | VACCINE | 2026-08-27 |
Related records
FdaNdcDirectoryPulse: Vaccine FdaNdcDirectoryPulse: Biologic (BLA)
How to monitor FLUZONE HIGH DOSE NORTHERN HEMISPHERE and peer biologic (bla) records
Get new FdaNdcDirectoryPulse records like FLUZONE HIGH DOSE NORTHERN HEMISPHERE by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new listings in your categories
FdaNdcDirectoryPulse emails new drug listings matching your pathway and product type.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.